Risperidone Related Raynaud's Phenomenon: An Adolescent Case
10.9758/cpn.2018.16.1.118
- Author:
Serkan GÜNEŞ
1
;
Ozalp EKINCI
;
Halenur TEKE
;
Veli YILDIRIM
Author Information
1. Department of Child and Adolescent Psychiatry, Hatay State Hospital, Hatay, Turkey. dr_sgunes@hotmail.com
- Publication Type:Case Report
- Keywords:
Raynaud's phenomenon;
Risperidone;
Adolescent;
Child;
Case report
- MeSH:
Adolescent;
Aripiprazole;
Bipolar Disorder;
Child;
Conduct Disorder;
Humans;
Male;
Risperidone;
Schizophrenia;
Serotonin Uptake Inhibitors;
Stress, Psychological;
Tic Disorders
- From:Clinical Psychopharmacology and Neuroscience
2018;16(1):118-121
- CountryRepublic of Korea
- Language:English
-
Abstract:
Raynaud's phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud's phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud's phenomenon associated with risperidone in a 12-year-old boy. Raynaud's phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.
